...
首页> 外文期刊>Kidney International: Official Journal of the International Society of Nephrology >Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation.
【24h】

Late and early C4d-positive acute rejection: different clinico-histopathological subentities in renal transplantation.

机译:晚期和早期 C4d 阳性急性排斥反应:肾移植中的不同临床组织病理学亚实体。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study was performed to investigate the clinical and pathologic features of C4d-positive steroid-resistant acute rejection (AR) at different phases after renal transplantation. Fifty-six kidney allograft recipients with C4d-positive AR were divided into three groups, very early rejection (VER, occurring 180 days following transplantation, n=23). Clinical and pathological features were evaluated. Significantly more patients in the ER and LR groups were associated with a reduction or withdrawal of immunosuppressants. More patients in the ER and LR groups experienced a significant (>3 g/l) decrease in serum albumin (80 ER, 91.3 LR, 7.1 VER, P1 g/dl) (80, 100 vs 17.9, P<0.001). Most VER patients reported a fever and had very rapid graft dysfunction requiring dialysis. Significantly more patients (87) had interstitial fibrosis and tubular atrophy in the LR group compared with the other groups and 13 had transplant glomerulopathy. Most cases of VER were reversed with tacrolimus and mycophenolate mofetil treatment, with or without immunoadsorption, with a 1-year survival rate of 96.4, compared with only 60 and 52.2 in the ER and LR groups. In conclusion, C4d-positive steroid-resistant AR at different time points is associated with unique clinico-histopathological manifestations requiring distinct treatment strategies. Late episodes are usually associated with significantly reduced serum albumin and hemoglobin levels and a poorer outcome. A more specialized treatment protocol should be established for these patients.
机译:本研究旨在探讨肾移植后不同阶段C4d阳性类固醇耐药急性排斥反应(AR)的临床和病理特征。将 56 例 C4d 阳性 AR 的同种异体肾移植受者分为三组,极早期排斥反应(VER,发生于移植后 180 天,n=23)。评估临床和病理特征。ER组和LR组中明显更多的患者与免疫抑制剂的减少或停药有关。ER组和LR组的患者血清白蛋白显著降低(>3 g/l)(80% ER,91.3% LR,7.1% VER,P1 g/dl)(80,100 vs 17.9%,P<0.001)。大多数 VER 患者报告发烧,并且移植功能障碍非常快,需要透析。与其他组相比,LR组的间质纤维化和肾小管萎缩的患者(87%)明显更多,移植肾小球病的患者(13%)明显更多。大多数 VER 病例通过他克莫司和吗替麦考酚酯治疗(有或没有免疫吸附)可逆转,1 年生存率为 96.4%,而 ER 和 LR 组仅为 60% 和 52.2%。总之,不同时间点的 C4d 阳性类固醇耐药 AR 与需要不同治疗策略的独特临床组织病理学表现相关。晚期发作通常与血清白蛋白和血红蛋白水平显著降低以及预后较差有关。应为这些患者制定更专业的治疗方案。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号